Evaluation of a New Non-Invasive Device for Detection of Endothelial Dysfunction

NCT00650741 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2008-04-02

No results posted yet for this study

Summary

The purpose of the study is to investigate the sensitivity and specificity of the Endotect compared with an ultrasound device in a flow-mediated vasodilatation (FMD) test.

Conditions

  • Endothelial Dysfunction

Sponsors & Collaborators

  • Lavi Cardiatec

    lead INDUSTRY

Principal Investigators

  • Giora Amitzur, Ph. D. · Heart Institute, Sheba Medical Center and Tel Aviv University, Israel

  • Michael Schechter, MD MA FACC · Heart Institute, Sheba Medical Center, Israel

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00650741 on ClinicalTrials.gov